Inventor
STAUNTON DONALD E
US15 patents
⚠️ This page may combine multiple inventors who share the name “STAUNTON DONALD E”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ICOS CORP
5 patentsUS5922570AJul 13, 1999
Cytoplasmic Modulators of Integrin Binding/Signalling
ICOS CORP6 citations68
US5958705ASep 28, 1999
Cytoplasmic modulators of integrin regulation/signaling
ICOS CORP5 citations57
US5948891ASep 7, 1999
Cytoplasmic modulators of integrin binding
ICOS CORP2 citations57
US5693483ADec 2, 1997
Cytoplasmic modulators of integrin binding/signalling
ICOS CORP3 citations53
US6210914B1Apr 3, 2001
Method to identify proteins which bind to integrin regulatory proteins
ICOS CORP1 citations47
BLOOD RES CENTER
4 patentsUS5288854AFeb 22, 1994
Functional derivatives of ICAM-1 which are substantially capable of binding to LFA-1 but are substantially incapable of binding to MAC-1
BLOOD RES CENTER79 citations94
US6797270B1Sep 28, 2004
Functional derivatives of the intercellular adhesion molecule ICAM-1 in anti-viral therapy
BLOOD RES CENTER12 citations73
US6777191B1Aug 17, 2004
Use of functional derivatives of the intercellular adhesion molecule ICAM-1 in diagnosis of viral infection
BLOOD RES CENTER10 citations73
US6436403B1Aug 20, 2002
Pharmaceutical composition of the intercellular adhesion molecule ICAM-1 for use in anti-viral prophylactic therapy
BLOOD RES CENTER11 citations73
DANA FARBER CANCER INST INC
4 patentsUS5565550AOct 15, 1996
Antibodies to ICAM-2, and fragments thereof
DANA FARBER CANCER INST INC21 citations89
US5489533AFeb 6, 1996
Isolated nucleic acid molecules encoding ICAM-2
DANA FARBER CANCER INST INC23 citations89
US6511664B1Jan 28, 2003
Intercellular adhesion molecule—2 and its binding ligands
DANA FARBER CANCER INST INC12 citations73
US5512660AApr 30, 1996
Purified ICAM-2 and fragment thereof
DANA FARBER CANCER INST INC14 citations71